comparemela.com

Latest Breaking News On - Society for laboratory automation - Page 15 : comparemela.com

ELRIG UK Announces Drug Discovery 2021 Event to Host SLAS s Innovation AveNEW

SLAS Discovery s July special edition Drug discovery targeting COVID-19 now available

SLAS Discovery s July special edition Drug discovery targeting COVID-19 now available
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

SLAS Technology June special issue on 3D cell culture

The June edition of SLAS Technology is a Special Issue entitled, Emerging Trends in 3D Cell Culture: High-Throughput Screening, Disease Modeling and Translational Medicine. Free online access to the articles in this collection is courtesy of Corning Life Sciences, the issue s sponsor.

SLAS Discovery s June issue on synthetic biology available now

The June edition of SLAS Discovery features the cover article, A Perspective on Synthetic Biology in Drug Discovery and Development Current Impact and Future Opportunities by Florian David, Ph.D. (Chalmers University of Technology, Gothenburg, Sweden), Andrew M. Davis, Ph.D. (AstraZeneca, Cambridge, England, UK). Michael Gossing, Ph.D., Martin A. Hayes, Ph.D., and Elvira Romero, Ph.D., and Louis H. Scott, Ph.D. (AstraZeneca, Gothenburg, Sweden), and Mark J. Wigglesworth, Ph.D. (AstraZeneca, London, England, UK).

SLAS Technology April issue dives into reactive oxygen species

Oak Brook, IL - The April edition of SLAS Technology features the cover article Therapeutic Potential of Reactive Oxygen Species: State of the Art and Recent Advances by Valeria Graceffa, Ph.D. (Institute of Technology Sligo, Sligo, Ireland). The cover article explores the therapeutic potential of reactive oxygen species (ROS) including applications ranging from wound healing and hair growth enhancement, to cancer treatment, stem cell differentiation and tissue engineering. At low concentrations, ROS can be utilized as inexpensive and convenient inducers of tissue regeneration, triggering stem cell differentiation and enhancing collagen synthesis. Recent cancer studies have represented ROS as the Achilles Heels of cancers given their high basal levels, leaving tumoral cells unable to sufficiently handle the additional source of oxidative stress. Because of this, higher doses of ROS are used for targeted killing of tumor cells. Lack of understanding of the technicalities betwe

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.